Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

HCA Healthcare Gets Price Target Bumps By Analysts After Upbeat Q1 Results

Published 24/04/2023, 12:56
© Reuters. HCA Healthcare Gets Price Target Bumps By Analysts After Upbeat Q1 Results

Benzinga - HCA Healthcare (NYSE: HCA) reported better-than-expected Q1 results and revised FY23 guidance.

HCA Healthcare reported Q1 FY23 revenues of $15.59 billion, compared to $14.94 billion a year ago, missing the consensus of $15.27 billion. EPS of $4.93 was higher than the $4.12 reported a year ago, surpassing the estimate of $3.93.

For FY23, HCA Healthcare raised revenues guidance to $62.5-$64.5 billion from $61.5-63.5 billion compared to the consensus Of $62.61 billion.

HCA Healthcare shares gained 3.9% to close at $281.21 on Friday, and added 0.1% in today’s pre-market trading session.

These analysts made changes to their price targets on HCA Healthcare following earnings announcement.

  • Citigroup raised the price target on HCA Healthcare from $293 to $324. Citigroup analyst Jason Cassorla maintained a Buy rating.
  • Oppenheimer increased the price target on HCA Healthcare from $270 to $310. Oppenheimer analyst Michael Wiederhorn maintained an Outperform rating
  • Credit Suisse increased the price target on HCA Healthcare from $282 to $311. Credit Suisse analyst A.J. Rice maintained the stock with an Outperform.

Read More: $59M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.